Summary of product characteristics (SPC) for Ilaris

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.

The summary of product characteristics (SPC) is a publicly available document approved as part of the marketing authorisation of each medicine. It contains more information than the patient information leaflet (PIL) and is aimed at healthcare professionals. It includes information about how to use the medicine, dosing, and any undesirable effects.

Patient information leaflet (PIL) for Ilaris

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.

The patient information leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

ILA20-C008h October 2020.
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.